These results confirm that SAMD4B is highly expressed in breast cancer, suggesting a potential role distinct from that of SAMD4A in breast cancer progression, although additional clinical studies are needed to substantiate these findings. This evidence concerns the gene SAMD4B and breast carcinoma.